公司資料
Exact Sciences 股價、新聞與催化劑
- 股票代碼:
- EXAS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for EXAS.
公司概覽
業務概覽
Exact Sciences is a molecular diagnostics company focused on cancer screening and precision oncology testing. Its most visible franchise is in colorectal cancer screening, but the broader business is built around non-invasive diagnostics and oncology-related testing.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Exact Sciences sits in diagnostics and molecular testing. It is a healthcare innovation company rather than a therapeutic biotech.
商業模式特徵
The company earns revenue from diagnostic test adoption, lab workflows, and cancer-screening expansion. Investors watch test volume, reimbursement, product rollout, and the potential for additional oncology diagnostics to broaden the franchise.
生技產業定位
Exact Sciences sits near the diagnostics edge of the biotech landscape. It is less binary than a drug developer but still sensitive to adoption trends, reimbursement, and product performance.
未來催化劑
- Exact Sciences’ catalysts are Cologuard Plus progress, screening utilization, and any regulatory or commercial update that broadens the early-detection franchise. The next checkpoint matters because it tells investors whether the program is still moving on schedule or whether the timeline needs to be reset. A clean outcome also makes it easier to think about the next regulatory or label step instead of just the current filing.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。